Rockefeller Capital Management L.P. Boosts Stock Position in Rentokil Initial PLC $RTO

Posted by Geri Gentry on Jun 23rd, 2026

Rockefeller Capital Management L.P. increased its stake in shares of Rentokil Initial PLC (NYSE:RTO – Free Report) by 5.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 816,863 shares of the company’s stock after purchasing an additional 40,024 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Rentokil Initial were worth $24,065,000 as of its most recent SEC filing.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Rentokil Initial by 222.2% in the 4th quarter. Caitong International Asset Management Co. Ltd now owns 1,163 shares of the company’s stock valued at $34,000 after buying an additional 802 shares during the period. GAMMA Investing LLC boosted its position in shares of Rentokil Initial by 76.5% in the 4th quarter. GAMMA Investing LLC now owns 1,232 shares of the company’s stock worth $36,000 after buying an additional 534 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new stake in shares of Rentokil Initial in the fourth quarter valued at about $39,000. IFP Advisors Inc lifted its stake in Rentokil Initial by 53.8% in the 3rd quarter. IFP Advisors Inc now owns 1,972 shares of the company’s stock valued at $50,000 after buying an additional 690 shares in the last quarter. Finally, EverSource Wealth Advisors LLC lifted its position in shares of Rentokil Initial by 296.3% in the fourth quarter. EverSource Wealth Advisors LLC now owns 1,954 shares of the company’s stock valued at $58,000 after acquiring an additional 1,461 shares in the last quarter. Institutional investors and hedge funds own 9.91% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts recently issued reports on RTO shares. Zacks Research downgraded shares of Rentokil Initial from a “hold” rating to a “strong sell” rating in a research note on Monday, June 15th. UBS Group raised Rentokil Initial from a “neutral” rating to a “buy” rating in a research note on Thursday, March 12th. Wall Street Zen cut shares of Rentokil Initial from a “buy” rating to a “hold” rating in a research report on Sunday, April 5th. Rothschild & Co Redburn upgraded Rentokil Initial from a “sell” rating to a “neutral” rating in a report on Wednesday, March 11th. Finally, Oppenheimer upped their price objective on shares of Rentokil Initial from $30.00 to $35.00 and gave the company an “outperform” rating in a research report on Tuesday, March 10th. One equities research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, three have given a Hold rating and two have given a Sell rating to the company. According to MarketBeat, Rentokil Initial has an average rating of “Moderate Buy” and an average target price of $34.50.

Get Our Latest Research Report on Rentokil Initial

Rentokil Initial Stock Performance

NYSE:RTO opened at $28.48 on Tuesday. Rentokil Initial PLC has a 12-month low of $22.72 and a 12-month high of $34.67. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.07 and a current ratio of 1.16. The business has a 50 day simple moving average of $31.81 and a 200 day simple moving average of $31.32.

About Rentokil Initial

(Free Report)

Rentokil Initial PLC is a global business services company specializing in pest control, hygiene and workwear services. Headquartered in Crawley, West Sussex, United Kingdom, the company delivers outsourced solutions designed to protect people, preserve assets and enhance workplaces for both commercial and residential customers.

Under the Rentokil Pest Control brand, the company offers services ranging from routine inspections and treatment of insects, rodents and birds to specialised programmes for food manufacturing and healthcare environments.